CryptoBreaking News

The top priority for new Apple CEO John Ternus should be revamping the company's design team and putting the focus back on the look and feel of products, writes Bloomberg's Mark Gurman in his latest Power On newsletter. He joins Ed Ludlow for more on "Bloomberg Tech."

Alan Greenspan, the former Federal Reserve chairman, has died at the age of 100 due to complications of Parkinson's disease. Greenspan served as Fed chief for 18 years, from 1987 to 2006, and was known for guiding a record US economic expansion, but his legacy was later dimmed by the financial crisis that erupted after he stepped down. In a statement on Monday, the Fed said, "Chairman Greenspan's legacy endures at the Federal Reserve in those he mentored directly, in the economists and public servants he inspired, and in the frameworks and practices he helped shape." Dennis Lockhart, former Atlanta Fed President, joins Bloomberg Intelligence Radio to discuss Greenspan's life and legacy, as well as what lies ahead for newly minted Chairman Kevin Warsh.

Chevron Corp. signed a 20-year deal with Microsoft Corp. to provide natural-gas fired power for a proposed West Texas data center, which could be one of the biggest in the US. The proposed plant, Project Kilby, is expected to start producing power by 2028 and will ramp up to 2.67 gigawatts over time, Houston-based Chevron said in a statement Monday. That's enough to power more than 530,000 Texas homes. The oil giant, which is collaborating on the development with investment fund Engine No. 1, plans to make a final investment decision later this year. Bloomberg News previously reported the companies were in exclusive talks over a long-term power deal. For more, we speak with Kevin Crowley, Bloomberg News Oil Reporter.

Randall Kroszner, University of Chicago Booth School of Business professor, and former Federal Reserve Governor, who worked with Alan Greenspan, says he got many calls right during his career, but the "one negative" needs to be acknowledged. Some say Greenspan policies contributed to the 2008 financial crisis. Kroszner speaks on "Bloomberg Open Interest."

Alan Greenspan has died at the age of 100. Greenspan's 18 years as Fed chief, from 1987 until his retirement at the start of 2006, were marked by a stock market boom and low unemployment. Bloomberg's Michael McKee reports on how Wall Street may see Greenspan's legacy.

US Vice President JD Vance said talks with Iran over the weekend were "very, very good," as the sides attempt to reach a peace deal within two months and formally end a war. Vance says a key point was building a mechanism to keep the Strait of Hormuz open. He spoke to reporters in Emmen, Switzerland where talks are being held.

Mackenzie Investments chief investment officer Lesley Marks and Morgan Stanley private wealth advisor and senior portfolio manager Katerina Simonetti discusses the US and Iran nuclear talks, their market outlook following the SpaceX IPO. They spoke with Guy Johnson on June 19, 2026.

Upside Co-Founder and CEO Alex Kinnier joins Bloomberg Open Interest to explain why American consumers are feeling squeezed despite falling gas prices, reveals what transaction data says about spending habits. He also discusses how AI is transforming retail with hyper-personalized offers that save consumers money while helping retailers grow profits.

Wall Street traders drove stocks down from the brink of all-time highs as a renewed slide in SpaceX overshadowed optimism about progress in peace talks between the US and Iran. Mamadou-Abou Sarr, President & Co-Founder of V-Square Quantitative Management discusses the markets and how he is encouraging diversified investing.

On this episode of Stock Movers with Nathan Hager: - Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report. - Regenxbio (RGNX) shares are moving on news Regenxbio aligned with the FDA on next steps for a potential accelerated approval of Navsunli, a gene therapy for Mucopolysaccharidosis II, with the FDA confirming the company doesn't need to conduct additional studies of the drug. - SpaceX (SPCX) is lower this morning, continuing its slide after its record IPO.

Alamos Gold CEO John McCluskey joins Bloomberg Open Interest to explain the seismic disruption behind the company's production cut, why he sees the setback as temporary, and why he rejects the idea that a weaker share price makes Alamos an M&A target.

Former Fed Governor Randy Kroszner joined Bloomberg Open Interest to break down Alan Greenspan's complicated legacy crediting him for fueling America's economic boom while acknowledging the risks that helped lead to the 2008 financial crisis. He also explains why the next era of the Federal Reserve could feature simpler communication and a renewed focus on long-term economic trends.